Discover Harrow Inc.'s growth strategy, bullish long-term prospects, and Q3 earnings outlook in ophthalmology. Click for more on HROW stock ahead of earnings.

Inflammasome Therapeutics ( a clinical-stage biotech company developing a new class of drugs, Kamuvudines, for ophthalmic and neurological conditions, announced the company has signed a contract with ...

Five startups have been awarded $10,000 Velocity Momentum Grants to help them take the next step in their entrepreneurial ...

Once, the humble carrot, celebrated for its beta-carotene and vitamin A, was considered the go-to food for healthy eyes. Today, however, a new trend is taking shape: chewable, fruit-flavoured gummy vi ...

The health, fitness and wellness worlds descend upon West Palm Beach this weekend for the second annual Eudēmonia Summit.

Completed enrollment with 530 subjects in the pivotal phase 3 PHOENIX trial in geographic atrophy (GA)Completed $15 million ...

In reality, Nova Eye is a poster child for the Make America Great Again (MAGA) manufacturing push, as it makes all its products at its facility at Fremont in San Francisco. What’s more, the company ...

We spoke to five Australian companies in Vienna seeking collaborators and capital at the BIO Europe partnering conference.

A new study reveals a concerning link between instant coffee and a sevenfold increased risk of dry age-related macular ...

Q3 2025 Earnings Call Transcript November 17, 2025 Operator: Good morning, ladies and gentlemen, and welcome to the NRx ...

For this month’s edition of 5 Interesting Startup Deals, all the funded companies that caught our eye were hardware-centric, from a medical device for at-home acne treatment, to an artificial retina ...

Q3 2025 Earnings Call November 17, 2025 8:30 AM ESTCompany ParticipantsMatthew Duffy - Chief Business Officer & ...